Nasdaq GlobeNewswire

DSM Sinochem Pharmaceuticals launches Atorvastatin film-coated tablets, expanding its finished dosage statins portfolio

Del

Rijswijk, 18 June 2018, June 18, 2018 (GLOBE NEWSWIRE) -- 
Building upon its first generic finished dosage statin launch (Rosuvastatin) in January of this year, DSM Sinochem Pharmaceuticals  (DSP) has this month released its fully backward-integrated, generic Atorvastatin drug product within the EU. Additional markets are scheduled to follow later in the year.Atorvastatin is used primarily in the prevention of cardiovascular disease and hyperlipidemia, commonly known as high cholesterol, the number one cause of death worldwide. Currently, statins are the most prescribed drug family globally in the fight against these potentially life-threatening conditions.

Expanding statins portfolio

With the launch now of Atorvastatin finished dosage formulation, coming on the heels of the successful launch of Rosuvastatin in January of 2018, DSP is actively expanding its statins drug product portfolio, realizing its aspiration of becoming a full-service generics pharmaceutical company. What sets DSP apart from competitors is its backward integration and secure control of its supply chain in the production of its finished drug products.

In 2012, DSP was the first pharmaceutical manufacturer worldwide to offer generic Atorvastatin active pharmaceutical ingredients (APIs) under a Certificate of Suitability (CEP).  Since 2014, DSP has produced enzymatic Atorvastatin API in its state-of-the-art facility in Toansa, India for third party customers, as well as now for its own new finished dosage formulation.

BU Director for Drug Products, Lucas Wiarda stated: "In utilizing our own in-house APIs to develop our finished dosage Atorvastatin, we deliver to both existing and future customers a product that offers unparalleled reliability.  Customers can trust that DSP's Atorvastatin is comprised of APIs from our own supply chain, which were first developed back in 2012.  Our statins portfolio now contains the two most popular products in the fight against cardiovascular disease and high cholesterol, and showcases our commitment to providing outstanding generic statins in this highly-competitive market."

In bringing Atorvastatin finished dosage formulation to the marketplace, DSP continues to deliver on its brand promise to customers, with Quality via world-class, differentiated active pharmaceutical ingredients, Reliability through an internal supply chain for all elements of producing a finished dosage product, and Sustainability at the forefront of its drug product production, using patented enzymatic technology which ensures an unmatched eco-friendly production process.

DSP holds an electronic Common Technical Document (eCTD) dossier for Atorvastatin finished dosage formulations (in 10, 20, 40, and 80 mg film-coated tablets, along with additional 30 and 60 mg strengths complementing the standard dosage range) suitable for climate Zone II (Mediterranean and subtropical zone), with a 24-month shelf life.  DSP is currently pursuing further stability studies to expand its filings to additional climate zones.

-----------

About DSM Sinochem Pharmaceuticals

DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next-generation statins and anti-fungals. DSP develops, produces and sells intermediates, active pharmaceutical ingredients and drug products. Our employees worldwide work together to deliver cutting-edge generics solutions that help to keep customers ahead of the competition.

Headquartered in Singapore, the group has manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico. DSP is a 50/50 Joint Venture of Royal DSM, a global science-based company active in health, nutrition and materials, and Sinochem Group, a Fortune 500 enterprise.

For more information please visit www.dsm-sinochem.com or contact DSM Sinochem Pharmaceuticals Corporate Communications, Geoff Vokes, Senior External Communications Manager. E-Mail: geoff.vokes@dsm-sinochem.com

Geoff Vokes
DSM Sinochem Pharmaceuticals
geoff.vokes@dsm-sinochem.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM Sinochem Pharmaceuticals via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Benchmark Discovers a Trove of Unsampled Historic Drill Core From Zones Including Assays of 87g/t Gold & 2,407g/t Silver Over 2.4m18.10.2018 09:00Pressemelding

EDMONTON, Alberta, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Benchmark Metals Inc. (the “Company” or “Benchmark”) (TSX-V: BNCH) (OTCQB: CYRTF) (GER: A2JM2X) (FKT: A7CA) is pleased to announce that 1,051 meters of newly sampled historical drill core has been sent to the laboratory for assays from the Lawyers Gold & Silver Project, located in the Golden Triangle region of British Columbia, Canada. CEO John Williamson commented, “Upon examination of historical drill core from the Lawyers Project, we have discovered 1,000 meters of mineralized core that were never sampled. From this material, we have sampled some holes from top to bottom, while others have been sampled on the shoulders, above and below historical high-grade intersections. As an example, we have sampled an extra 197 meters of core from drill hole CC15-15, which had previously returned an intersection of 87g/t gold and 2,407g/t silver over 2.4m, but this was never followed up with complete shoulder sampling. The potential to increas

UPDATE - Euro Manganese Inc. Closes Plant Site Option Agreement and Provides Operational Update18.10.2018 04:01Pressemelding

VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V/ASX: EMN) (“EMN” or the "Company") announced today that it has waived the conditions precedent to the closing of an Option Agreement to acquire EP Chvaletice s.r.o. (“EPCS”), a Czech operating company whose principal asset is a large parcel of industrial zoned land adjacent to the Chvaletice Manganese Project, where EMN proposes to develop its high-purity manganese processing facility. In addition, EMN is pleased to provide an operational update for its Chvaletice Manganese Project. Due Diligence Completed and First Payment made on EPCS Option Agreement Following the satisfactory completion of an environmental, financial and legal due diligence review, the Company reports that it has made the first instalment of 14 million Czech Korunas (approx. CAD$815,000) related to an option agreement dated August 13, 2018 giving it the right to acquire a 100% interest in EPCS (the “Option Agreement”). EPCS is

Euro Manganese Inc. Closes Plant Site Option Agreement and Provides Operational Update17.10.2018 22:58Pressemelding

VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V/ASX: EMN) (“EMN” or the "Company") announced today that it has waived the conditions precedent to the closing of an Option Agreement to acquire EP Chvaletice s.r.o. (“EPCS”), a Czech operating company whose principal asset is a large parcel of industrial zoned land adjacent to the Chvaletice Manganese Project, where EMN proposes to develop its high-purity manganese processing facility. In addition, EMN is pleased to provide an operational update for its Chvaletice Manganese Project. Due Diligence Completed and First Payment made on EPCS Option Agreement Following the satisfactory completion of an environmental, financial and legal due diligence review, the Company reports that it has made the first instalment of 14 million Czech Korunas (approx. CAD$815,000) related to an option agreement dated August 13, 2018 giving it the right to acquire a 100% interest in EPCS (the “Option Agreement”). EPCS is

Constellation Brands Names Bill Newlands Next CEO17.10.2018 22:55Pressemelding

Newlands to Succeed Rob Sands Effective March 1, 2019; Sands to Become Executive Chair VICTOR, N.Y., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, today announced Bill Newlands will assume the role of president and chief executive officer (CEO), succeeding current CEO Rob Sands, on March 1, 2019. Also effective March 1, 2019, Rob Sands will assume the role of executive chair. Richard Sands, who is currently serving in the role of executive chair, will assume the role of executive vice chair on March 1, 2019. “Since joining Constellation Brands in 2015, Bill has made a significant impact on our company, finding ways to leverage our unique capabilities as a leading total beverage alcohol provider to meet consumers’ evolving needs and accelerate growth,” said Constellation Brands’ CEO Rob Sands. “Bill understands what it takes to succeed in this rapidly evolving market and he’s the right person to lead our company g

Elite Capital & Gas broadens financial services and signs a deal with Tabarak Investment Capital Limited17.10.2018 16:30Pressemelding

DUBAI, United Arab Emirates, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Today the President of Elite Petro & Gas, Mr. George Matharu and the President of Tabarak Investment Capital Limited (Investment Bank), Dr. Mohamed Ahmadi announced a deal in which the two companies will use their combined resources to execute physical commodity trades, and provide banking and finance facilities for oil and gas transactions. The alliance between the two entities will also allow compliance related activities to be carried out from two major international hubs of London and Dubai. This increases the international presence of both companies. Additionally, Elite Petro & Gas (“EPG”) has recently formed relationships with the owners of a number of high profile European, South American and Chinese projects, which EPG and Tabarak can work on together. Tabarak Investment Capital Limited is a regulated investment bank by Dubai Financial Services Authority and incorporated in the Dubai International Financial Centre.

MASH ANNOUNCES EUR 50M EQUITY ROUND AND LAUNCH OF EUROPE'S FIRST STO17.10.2018 15:14Pressemelding

Mash Group, a ten year old digital lender and pay later solution provider, announced a EUR 50M equity round and the launch of a Security Token Offering (STO) Helsinki, 17th October: Mash Group Plc, a Finnish FinTech company specializing in consumer lending and pay later solutions, today announced that pre-registration has begun for a Securitized Token Offering (STO). Mash is partnering with DLA Piper, Trust and Tokeny to offer professional investors the means to participate in the current equity round using both crypto and fiat currency. Deloitte has been selected to provide AML and KYC services. The whitelisting process will begin in October with the round closing in December 2018. The STO is part of Mash’s broader EUR 50 million equity round. Security tokens are not the same as utility tokens, as have been issued in a number of recent initial coin offerings (ICOs). The Mash security tokens are backed by assets and token holders would have voting rights and dividend rights of the comp

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom